Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Collagen type XX alpha 1 chain (COL20A1) is a protein encoded by the COL20A1 gene in humans and is part of the collagen superfamily, a large group of extracellular matrix proteins that provide structural support to connective tissues. Type XX collagen is one of the lesser-characterized collagen types, and functional information remains limited. Initial studies suggest it may play roles in the formation and maintenance of specific connective tissues. Rare genetic variants in COL20A1 have been proposed as candidates associated with striate palmoplantar keratoderma (PPKS), expanding the spectrum of genetic contributors to this disorder. Detailed molecular roles, disease associations, and potential as a therapeutic target have not been established in the current literature[4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Collagen type XX alpha 1 chain (COL20A1).